We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Christopher R. Moore

Silicon Valley

Christopher R. Moore

Chris Moore represents acquirors, targets, boards of directors, investment banks, and investors in complex domestic and cross-border merger and acquisition transactions as well as joint ventures, with a focus on the technology and life sciences sectors.

Chris's recent experience includes billions of dollars of M&A activity for some of the world's top technology and life sciences companies as well as investment banks in connection with their roles as financial advisors on M&A transactions.

Representative experience

Marvell Technology Group Ltd. in its pending approximately US$6bn acquisition of Cavium, Inc.

Synopsys in its US$565m acquisition of Black Duck Software, Inc.

Dialog Semiconductor in its US$276m acquisition of Silego Technology, Inc.

Zulily in its US$2.4bn sale to Liberty Interactive Corporation.*

Eli Lilly in its US$960m acquisition of CoLucid Pharmaceuticals.*

XenoPort in its US$446.6m sale to Arbor Pharmaceuticals.*

Adobe in its acquisition of Aviary.*

Synopsys in its acquisitions of Protecode, Gold Standard Simulations, Cigital, and Codiscope.*

Telstra Corporation in its acquisition of Ooyala.*

*Matter handled prior to joining Hogan Lovells.

Education and admissions


  • J.D., University of California, Los Angeles, School of Law, 2008
  • B.A., cum laude, University of California, Los Angeles, 2004


  • Member, Working Group for the ABA 2016 Strategic Buyer/Public Target M&A Deal Points Study
  • Member, Study Leadership Group for the forthcoming ABA M&A Carveout Transactions Deal Points Study

Bar admissions and qualifications

  • California
  • New York

Latest thinking and events

View More
Loading data